Name: J.LAMARCK BIOTECH
Inv. Manager: SELECTRA Management Company S.A.
Inv. Advisor: J.LAMARCK S.p.A.
Strategy: The focus is on mature top tier pharmaceutical biotech companies and companies with interesting pipeline of products in development in a single or numerous markets, like NASDAQ or NYSE. The followed investment policy will enable the Sub-Fund to increase overall return relative to the Nasdaq Biotech Index by active stock selection of companies, offering the most promising technology platform.
Geographical Area: Worldwide
Asset Class: Equity Fund